Skip to Main Content

Healthwise® Health Information

Health library

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. 0-9

Tattoos: Reporting Problems

Top of the page

Tattoos: Reporting Problems

Overview

The U.S. Food and Drug Administration (FDA) encourages everyone to report adverse reactions to permanent and temporary tattoos and permanent makeup to the FDA's MedWatch. This agency monitors problems caused by cosmetic products and ingredients, including color additives.

To report a problem, contact MedWatch:

  • By mail: MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
  • Online: https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reporting.home

Related Information

Credits

Current as of: November 16, 2023

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: November 16, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

To learn more about Ignite Healthwise, LLC, visit webmdignite.com.

© 2024 Ignite Healthwise, LLC. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Ignite Healthwise, LLC.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.